news
ADHD drugs unlikely to cause cardiac damage in children
The results of a long-term study on the use of ADHD medication has advised that they are unlikely to result in heart damage, or cardiac difficulties...
List view / Grid view
Food and Drug Administration (FDA)
news
FDA approves treatment for peripheral T-cell lymphoma
The US Food and Drug Administration has approved first-line treatment for newly diagnosed peripheral T-cell lymphoma using a new review program...
news
Fixed-combination drug products for hypertension treatment
The FDA has released a set of guidance notes for sponsors looking to combine approved hypertension drugs for more effective treatments...
news
One month until the DSCSA: are manufacturers prepared?
With just under one month until the Drug Supply Chain Security Act is enforced in the US, manufacturers are still not all compliant with the rulings...
news
Smart pills could ‘dumb down’ medical care
Research suggest that the use of smart pills should be only after carefully evaluating their clinical efficacy against standard of care drugs...
news
FDA approves the inclusion of new evidence for Cosentyx in PsA
The FDA has approved the inclusion of new evidence that Cosentyx significantly slows the progression of joint structural damage..
article
Quality by design and single-use air sampling
Quality by Design (QbD) is a method approach to developing a quality control system using predetermined objectives. It uses the foundations of risk management and science to ensure a repeatable process to manufacture high-quality products. In 2002, the FDA launched QbD as part of its innovation initiative. This paper outlines…
news
Poliovirus therapy induces immune responses against cancer
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
news
India’s pharmaceutical market set to hit $100bn by 2025
The future looks bright for India’s pharmaceutical environment says Vanaja Krishnan, Managing Director of George Clinical, India
news
PDA issues essential new guidance for visual inspections
A new technical report has clarified best practice on visual inspection for visible particles in parenterals.
news
Rise in product recalls prompts FDA to warn of possible BCC contamination
The US Food and Drug Administration (FDA) has advised manufacturers of non-sterile, water-based drug products that there have been recent product recalls due to Burkholderia cepacia complex (BCC) contamination.
news
Pfizer and Lilly receive FDA fast track designation for tanezumab
The FDA has granted fast track designation for Pfizer and Eli Lilly’s tanezumab for the treatment of chronic pain in patients with osteoarthritis...
news
Precision Polymer Engineering will be exhibiting at Making Pharmaceuticals
19 April 2017 | By Precision Polymer Engineering
Precision Polymer Engineering will be at Stand 303 at Making Pharmaceuticals (25-26 April, Coventry, UK), offering the benefits of our experience in pharmaceutical sealing to solve problems for critical process applications...
news
Wickham Labs to Exhibit at Pharmig 2016
3 November 2016 | By Wickham Laboratories Limited
Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th...
news
Wickham Laboratories Announces Renewal of FDA Accreditation
20 October 2016 | By Wickham Laboratories
Wickham Laboratories reports a successful completion of the FDA auditing process with renewal of GMP accreditation....
